tm logo
T
Live/Registered
REGISTERED

on 19 Feb 2019

Last Applicant/ Owned by

10 Earlsfort Terrace

Dublin 2

IE

DO2T380

Serial Number

87519964 filed on 07th Jul 2017

Registration Number

5681387 registered on 19th Feb 2019

in the Principal Register

Correspondent Address

Miriam D. Trudell

Sheridan Ross P.C.

1560 Broadway, Suite 1200

Denver CO 80202

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

T

Medical devices, namely, implantable subcutaneous drug delivery devices sold empty; implantable subcutaneous drug delivery devices sold empty but used in the treatment of cancer; medical apparatus, namely, injection devices for pharmaceuticals The color(s) red, dark gray, light gray and black is/are claimed as a feature of the mark. Pharmaceutical and medical preparations for the treatment of arRead More

Classification Information


Class [010]
Medical Instrument Products


Medical devices, namely, implantable subcutaneous drug delivery devices sold empty; implantable subcutaneous drug delivery devices sold empty but used in the treatment of cancer; medical apparatus, namely, injection devices for pharmaceuticals


First Use Date in General

07th Nov 2018

First Use Date in Commerce

07th Nov 2018

Class [005]
Pharmaceutical Products


Pharmaceutical and medical preparations for the treatment of arthritis, autoimmune diseases, the immune system, the respiratory system, musculoskeletal system, genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, in gynecology and urology, for use in gastroenterology, and antibacterials, anti-virals, antibiotics and anti-fungals for the treatment of viral and bacterial infections; pharmaceutical preparations for the treatment of central precocious puberty; pharmaceutical delivery systems comprising implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the palliative treatment of advanced prostate cancer; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a variety of pharmaceuticals; pharmaceutical preparations for the treatment of cancer; drug delivery systems, namely, drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer; pharmaceutical delivery systems comprising an active pharmaceutical ingredient in a biodegradable polymer for the continuous release of a wide variety of therapeutic agents


First Use Date in General

19th Nov 2018

First Use Date in Commerce

19th Nov 2018

Mark Details


Serial Number

No 87519964

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 6934TILT-5

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.03 -

Incomplete circles (more than semi-circles)

26.01.12 -

Circles with bars, bands and lines

26.01.21 -

Circles that are totally or partially shaded

Description of Design Search

The mark consists of a stylized letter "T" in a circle. The circle is divided horizontally by a transparent band as the horizontal top portion of the letter "T", with the top half of the circle having a black outline with part of the left portion of the circle in dark gray and the remaining right potion in light gray. The lower half of the circle is divided by a vertical transparent band as the bottom vertical portion of the letter "T", with the circle being divided by the band into two parts, both being red. The color white represents background, outlining, shading and/or transparent areas and is not part of the mark.

Legal History


Show more

Status DateAction Taken
19th Feb 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02th May 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
02th May 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02th May 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02th May 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
02th May 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19th Feb 2019REGISTERED-PRINCIPAL REGISTER
17th Jan 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16th Jan 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15th Jan 2019STATEMENT OF USE PROCESSING COMPLETE